Viking Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
VKTX chart
What traders are saying about $VKTX
Latest postsViking Therapeutics, Inc. news
- Viking Therapeutics stock trades at 26.00 euros Tuesday
ad-hoc-news.de ·
- The FDA Ordered GLP-1 Vision-Loss Warnings For Some Products. Shares of Eli Lilly and Novo Nordisk Were Unfazed.
ibtimes.com ·
- Viking Therapeutics Inc (1VT.SG) Seasonal returns chart
Yahoo Finance UK ·
- Viking Therapeutics (VKTX) Moved, What Is Drawing Attention Now?
Simply Wall St ·
- Novo Up 4% in a Month: How Should Investors Approach the Stock Now?
Yahoo Finance ·
- Viking Therapeutics to present Phase 3 and 2 tr...
Pluang ·
- Viking Therapeutics Announces Two Poster Presentations at ObesityWeek® 2026
Yahoo Finance ·
- Viking Therapeutics (VKTX) Stock Price, Chart & Analysis
www.debelegger.nl ·
- Viking Therapeutics Moves Closer To Challenging Ozempic With Phase 3 Trial Progress
Stocktwits ·
- Viking Therapeutics stock trades at 24.20 euros on Saturday
ad-hoc-news.de ·
- Viking Therapeutics (VKTX) Institutional Ownership 2026 $VKTX
MarketBeat ·
- Viking Therapeutics, Inc. (VKTX) Options Chain - Yahoo Finance
Yahoo! Finance Canada ·
Viking Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net income | -$359.6M | -$110.0M | -$85.9M | -$68.9M |
| Diluted EPS | $-3.19 | $-1.01 | $-0.91 | $-0.90 |
| Total assets (year end) | $715.7M | $908.3M | $368.5M | $168.5M |
| Cash and equivalents (year end) | $165.8M | $26.7M | $55.5M | $36.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Viking Therapeutics, Inc.
- Ticker
- VKTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1607678
Frequently asked questions
What exchange is Viking Therapeutics, Inc. listed on?
Viking Therapeutics, Inc. trades on the Nasdaq under the ticker symbol VKTX.
What industry is Viking Therapeutics, Inc. in?
Viking Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Viking Therapeutics, Inc. headquartered?
Viking Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Viking Therapeutics, Inc.'s fiscal year end?
Viking Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Viking Therapeutics, Inc. report?
Viking Therapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.